Experts explore treatment considerations when treating patients with metastatic breast cancer with elacestrant, including dosing, patient selection, adherence, and treatment duration. Participants also discuss dose modifications, adherence concerns, and how they determine treatment failure.
This is a video synopsis/summary of a Peer Exchange featuring Mabel Mardones, MD; Rena Callahan, MD; William Gradishar, MD; and Gregory Vidal, MD, PhD.
Mardones explores considerations for using oral selective estrogen receptor degraders (SERDs) with Callahan, Vidal, and Gradishar. Callahan highlights patients for whom she wouldn’t consider oral SERDs, emphasizing the need for alternatives in visceral crisis situations. Vidal discusses the recommended dose schedule, dose modifications, and potential adherence concerns, noting the convenience of oral therapy despite adherence challenges. Gradishar emphasizes the continuous and individualized treatment duration, which continues for as long as the patient responds and tolerates the therapy. Callahan sheds light on determining treatment failure, emphasizing the importance of definitive disease progression rather than relying solely on liquid biopsy results. The discussion provides insights into patient selection, dosing considerations, adherence challenges, and duration of treatment with oral SERDs, offering practical guidance for clinicians.
Video synopsis is AI-generated and reviewed by AJMC® editorial staff.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More